“Alliance Growers – Establishing a Long Term Presence in the Cannabis Industry Through Diversity, Science and Technology.”
Fawzia Afreen Ph.D.
Pharmagreen Biotech Inc. Chief Operations Officer
Fawzia has a Ph.D. in Botany from University of Hull (UK). She has achieved designation as a JSPS Fellow from Chiba University, Japan, teaching M.Sc. courses in (I) Protected Horticulture; (ii) Plant Tissue Culture, and (iii) Plant Production in Controlled Environment.
In addition to holding three international patents, publishing over 40 articles in peer-reviewed international journals and publishing two books, Fawzia brings 16 years of experience in plant horticulture, plant tissue culture, plant production and an increase of secondary metabolites in a controlled environment to the company.
Biocannatech has completed the security clearance stage of Health Canada’s Federal regulations for approval for the production and sales of Medical Marijuana.
Biocannatech Inc. leased a 10,000 square foot facility in Mount-Royal, Québec. Permits have been filed with the municipality to renovate the facility.
Biocannatech Inc. also leased the adjacent facility. This facility is 17,900 square feet with a growing area of 16,000 square feet.
Cannabis Biotech Complex
The first Cannabis Biotech Complex being developed in Mission, BC by Alliance Growers in concert with WFS Pharmagreen, through jointly owned 1155097 BC Ltd., will primarily produce plant clones called “plantlets” as a service for cannabis growers to maintain consistent plant strains. The complex will also house facilities for cold storage of plants, CBD oil extraction, and allow our R&D licensor, Botanical Research In Motion International Inc. (B.R.I.M.), to continue developing new technologies in house.
The plantlet supply contracts the Cannabis Biotech Complex offers will also secure “offtake” agreements for flowers at wholesale cost to be used in CBD oil extraction. These contracts will be made with both external growers as well as Alliance Growers’ own associated producers.
CBD ‘DANA’ Hemp Strain
Alliance Grower has secured access to a proprietary CBD strain named “CBD DANA,”. The unique strain has been tested for a content of at least 10% CBD and less than 0.3% THC. This CBD yield is substantially greater than traditional hemp strains which typically have at most a 1% content. The lower THC content allows the strain to be classified as “industrial hemp” which makes it ideal for cultivation with less restrictive regulation.
The female plantlets produced in the Tissue Culture Lab at the Cannabis Biotech Complex will be available for hemp farmers on a global scale. Providing hemp farmers with all female, fully rooted plantlets of the strain will provide a significant yield in CBD production for hemp farmers.
“Building a diversified global cannabis company
focused not on where the market is today, but where it is going.”
Alliance Growers Corp. was incorporated 2014 in Vancouver, Canada and is publicly traded on the Canadian Stock Exchange under symbol ACG, on the OTCQB under ALGWF, and on the Frankfurt Stock exchange under 1LA. The Company is dedicated to building shareholder value with its focus on the regional and international regulated medical cannabis market.
Our “Four Pillars” strategy maps out a network between licensed cannabis growers, cannabidiol (CBD) oil extractors, new agricultural technologies, and the jointly owned Cannabis Biotech Complex.